Basic concepts for genetic testing in common hereditary colorectal cancer syndromes

Area of Science:

• Oncology
• Genetics
• Hereditary Cancer Syndromes

Background:

• ~5% of colorectal cancers stem from autosomal dominant hereditary cancer syndromes.
• Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC) are the most prevalent familial colon cancer syndromes.
• Genetic testing can identify causative mutations in affected individuals from these families.

Purpose of the Study:

• To outline the genetic testing strategy for HNPCC and FAP.
• To explain how genetic testing aids in personalized cancer surveillance.
• To highlight the importance of genetic counseling in interpreting results and managing patient expectations.

Main Methods:

• Identifying causative mutations through genetic testing of affected individuals.
• Performing genetic testing on at-risk, unaffected family members.
• Developing personalized cancer surveillance plans based on test results.

Main Results:

• Genetic testing accurately identifies individuals who have inherited cancer-susceptibility mutations.
• Personalized surveillance strategies can be implemented for at-risk family members.
• Genetic testing significantly improves cancer risk assessment within families.

Conclusions:

• Genetic testing is a powerful tool for assessing cancer risk in families with FAP and HNPCC.
• Effective implementation requires patient education, informed consent, and physician expertise due to complex interpretation and emotional impact.
• This strategy allows for tailored cancer surveillance, improving outcomes for hereditary colon cancer syndromes.